Literature DB >> 24476936

Hypertrophic cardiomyopathy: implications for anesthesia.

M Vives1, A Roscoe.   

Abstract

Hypertrophic cardiomyopathy (HCM) is a genetic disorder and it is recognized as the most common cause of sudden cardiac death in the young, and an important substrate for disability at any age. Anesthetists may be confronted with clinically unrecognized HCM and must be prepared to anticipate the hemodynamic changes and cardiovascular instability that such patients may impose. When HCM patients are subjected to the stress of surgery, perioperative complications occur and can be devastating. Anesthesia providers need to be aware of the relevant pathophysiology and the mechanisms that may trigger or accentuate dynamic left ventricle outflow tract obstruction. Factors that worsen the degree of left ventricle outflow tract obstruction and hemondynamic strategies to improve cardiac outoput are described in the present review. Strategies to respond to hypotension must be promptly instituted to prevent the development of cardiovascular collapse, and subsequent complications. Therefore, a complete understanding of the pathophysiology, hemodynamic changes and anesthetic implications is needed for successful perioperative outcome.

Entities:  

Mesh:

Year:  2014        PMID: 24476936

Source DB:  PubMed          Journal:  Minerva Anestesiol        ISSN: 0375-9393            Impact factor:   3.051


  2 in total

1.  Papillary Thyroid Carcinoma Treated with Radiofrequency Ablation in a Patient with Hypertrophic Cardiomyopathy: A Case Report.

Authors:  Jianyi Sun; Xiaosun Liu; Qing Zhang; Yanyun Hong; Bin Song; Xiaodong Teng; Jiren Yu
Journal:  Korean J Radiol       Date:  2016-06-27       Impact factor: 3.500

2.  Hypertrophic cardiomyopathy surgery: Perioperative anesthetic management with two different and combined techniques.

Authors:  José J Arcas Bellas; Cristina Sánchez; Ana González; Alberto Forteza; Verónica López; Javier García Fernández
Journal:  Saudi J Anaesth       Date:  2021-04-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.